Royal Bank of Canada »

Reneo Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0k 2.8k 1.45
2023-09-30 $13k 2.0k 6.37
2023-06-30 $4.6k 952 4.78
2022-09-30 $0 75 0.00
2021-06-30 $4.0k 431 9.28

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
UnitedHealth (UNH)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
Ikarian Capital
Highbridge Capital Management
Vanguard Group
Aisling Capital Management
Caption Management
Two Sigma Investments
Millennium Management
LMR Partners
GSA Capital Partners

View all funds holding Reneo Pharmaceuticals